Evidence on the acute and residual neurocognitive effects of cannabis use in adolescents and adults: a systematic meta-review of meta-analyses.
Laura Dellazizzo, Stéphane Potvin, S. Giguère, A. Dumais
Addiction January 19, 2022 DOI: 10.1111/add.15764 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Meta-review (systematic review of meta-analyses) Peer reviewed |
|---|---|
| Sample size | 43,761 |
| Population | Adolescents and adults from the general population who use cannabis |
| Intervention | Cannabis |
| Topics | Cannabis |
| Key findings | Across 10 meta-analyses (71 effect sizes, n=43,761), cannabis intoxication produced small-to-moderate deficits in several cognitive domains, most robustly in verbal learning and memory, which persisted after intoxication passed. Executive functioning, processing speed, attention, and simple motor skills showed small-to-moderate acute and residual effects, while language showed no significant difference between users and non-users. The authors conclude that these acute impairments align with documented residual effects, suggesting cannabis-related cognitive deficits persist beyond acute intake. |
Abstract
Background: Cannabis is among the most consumed psychoactive substances world-wide. Considering changing policy trends regarding the substance, it is crucial to understand more clearly its potential acute and residual adverse effects from a public health viewpoint. Cognitive function is one of the targeted areas with conflicting findings. This meta-review measured the magnitude of acute and residual effects of cannabis on cognition in adolescents and adults provided by meta-analyses and evaluated quality of evidence.
Methods: A systematic search was performed in PubMed, PsycINFO, Web of Science and Google Scholar. Meta-analyses were included if they quantitatively examined the performances of users from the general population on cognitive tasks.
Results: The search retrieved 10 eligible meta-analyses (71 effects sizes, n = 43 761) with evidence ranging from low to moderate quality, which were categorized into domains of cognitive functions: executive functions (k = 7), learning and memory (k = 5), attention (k = 4), processing speed (k = 5), perceptual motor function (k = 2) and language (k = 2). Verbal learning and memory displayed the most robust evidence and were most impaired by acute cannabis intoxication that persisted after intoxication passed. Small-to-moderate acute and residual adverse effects were reported for executive functioning. Cannabis use led to small deficits in inhibitory processes and flexibility, whereas small-to-moderate deficits were reported for working memory and decision-making. Evidence regarding processing speed and attention has shown that cannabis administration induced small-to-moderate adverse effects and residual neurocognitive deficits were observed in heavy cannabis-using youths. Results showed no significant difference between cannabis users and non-users on language, and small-to-moderate effects for simple motor skills.
Conclusion: Meta-analytical data on the acute effects of cannabis use on neurocognitive function have shown that cannabis intoxication leads to small to moderate deficits in several cognitive domains. These acute impairments accord with documented residual effects, suggesting that the detrimental effects of cannabis persist beyond acute intake.
Comparable studies
Other systematic reviews and meta-analyses on cannabis, most cited first.
| Study | Year | Design | Participants |
|---|---|---|---|
| Effects of cannabis use on outcomes of psychotic disorders: systematic review People with psychotic disorders, as examined in 13 longitudinal studies | 2008 | Systematic review | |
| The Impact of Cannabis Use on Cognitive Functioning in Patients With Schizophrenia: A Meta-analysis of Existing Findings and New Data in a First-Episode Sample Patients with established schizophrenia (meta-analysis: 572) and patients with... | 2010 | Meta-analysis and cross-sectional observational study | n = 700 |
| Medicinal cannabis for psychiatric disorders: a clinically-focused systematic review | 2020 | Systematic review | |
| Neuroimaging in cannabis use: a systematic review of the literature Cannabis users and controls in neuroimaging studies | 2009 | Systematic review | |
| Human Laboratory Studies on Cannabinoids and Psychosis. Healthy human subjects and individuals with schizophrenia | 2016 | Systematic review |
Citations in the library
Cited by 26
- Effects of naturalistic doses of cannabis edibles on cognition and association with blood THC. Psychopharmacology March 1, 2026
- Identifying EEG markers related to acute cannabis consumption: A systematic review. Neuroscience & Biobehavioral Reviews May 1, 2025
- Cognitive Outcomes among Cannabis Users with and without a History of Polysubstance Use Journal of Cognitive Enhancement September 14, 2026
- Motion and form perception in healthy individuals with adolescent cannabis use Frontiers in Psychiatry August 17, 2026
- A Meta-Analysis of Cannabis Research: Evidence of Lasting Neurocognitive Effects Continues to be Lacking Cannabis May 6, 2026
and 21 more in the library
Cites 26
- High-potency cannabis and the risk of psychosis The British Journal of Psychiatry November 30, 2009
- Modulation of Mediotemporal and Ventrostriatal Function in Humans by Δ9-Tetrahydrocannabinol Archives of General Psychiatry April 1, 2009
- The neuropsychopharmacology of cannabis: A review of human imaging studies Pharmacology & Therapeutics October 20, 2018
- Smoked Cannabis' Psychomotor and Neurocognitive Effects in Occasional and Frequent Smokers Journal of Analytical Toxicology March 4, 2015
- The Behavioral Sequelae of Cannabis Use in Healthy People: A Systematic Review Frontiers in Psychiatry February 16, 2021
and 21 more in the library